Allianz Asset Management Gmb H Beam Therapeutics Inc. Transaction History

Allianz Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$68.02 - $99.06 $200,659 - $292,227	-2,950 Reduced 15.93%	15,565 $1.25 Million
Q3 2021 Nov 10, 2021	BUY	$84.37 - $133.6 $638,680 - $1.01 Million	7,570 Added 69.16%	18,515 $1.61 Million
Q2 2021 Aug 16, 2021	SELL	$64.12 - $128.71 $86,241 - $173,114	-1,345 Reduced 10.94%	10,945 $1.41 Million
Q1 2021 May 13, 2021	SELL	$71.28 - $120.75 $270,151 - $457,642	-3,790 Reduced 23.57%	12,290 $984,000
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $357,619 - $1.54 Million	16,080 New	16,080 $1.31 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.